Computational immunology is an interdisciplinary field that leverages computational and mathematical approaches to analyze complex immune system dynamics, understand immunological processes, and predict immune responses. This field plays a crucial role in advancing our understanding of immune system function, host-pathogen interactions, and the development of immune-related disorders. Using computational models, bioinformatics, and data-driven techniques, computational immunologists analyze large-scale biological data, such as genomics, proteomics, and high-throughput sequencing data. These approaches help identify patterns, pathways, and potential biomarkers associated with immune responses and diseases. Computational immunology contributes to vaccine design, drug development, and personalized medicine by simulating immune responses, predicting antigen-antibody interactions, and optimizing treatment strategies. Machine learning and artificial intelligence techniques are increasingly employed to analyze complex immunological datasets and make predictions. This field also facilitates the integration of diverse data sources, aiding in the discovery of novel immunological insights. Computational models help simulate immune responses in various scenarios, contributing to our ability to understand and predict the outcomes of different immunotherapies. As computational immunology continues to evolve, it serves as a powerful tool for unraveling the intricacies of the immune system, accelerating discoveries in immunological research, and informing the development of innovative strategies for diagnosing and treating immune-related disorders.
Title : Personalized and Precision Medicine (PPM) via biodesign-driven translational applications and upgraded business modeling to secure the human biosafety: The next-step vaccinomics of the future
Sergey V Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : The promise of nanotechnology in Personalized & Precision Medicine: Nano-driven precision vaccinomics of the future
Sergey V Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Recombinant BCG vaccine as a potent anti tuberculosis vaccine candidate
Sajal Dey, BRIC-Centre for DNA Fingerprinting and Diagnostics, India
Title : Emerging nanovaccine strategies for enhanced immune targeting and vaccine performance
Aysel Sadayli, V.Y. Axundov Scientific-Research Institute of Medical Prophylaxis, Azerbaijan
Title : Advancing vaccine availability and equity in low-resource settings: Evidence from Awendo Sub-County, Kenya
Millicent Ochieng, Clinton Health Access Initiative, Kenya
Title : Reaching zero-dose children through adaptive immunization strategies in security-compromised areas of Zamfara State, Nigeria
Attahir Abubakar, Ahmadu Bello University, Nigeria
Title : From local pilots to national policy: Key issues and challenges in implementing nationwide HPV vaccination in China
Shenglan Tang, Duke Global Health Institute, United States